FACIT

FACIT is an award-winning commercialization venture firm that builds companies with entrepreneurs to accelerate oncology innovations, with a portfolio that has attracted more than $1.7 billion in investment to Ontario. Blending industry experience, capital and the unsurpassed clinician-scientist network of its strategic partner, the Ontario Institute for Cancer Research (OICR), FACIT capitalizes on the province’s investment in research and healthcare to the benefit of the local economy and patients worldwide. FACIT brings together entrepreneurial scientists, partner institutions and other key players involved in the commercialization of life science innovations in Ontario. By applying venture capital and market-driven investing principles, our experts identify, access and support technologies with top potential for addressing unmet oncology needs. As an active partner, we provide capital, experienced executive management and connections to our industry and investor network, empowering companies to grow roots and scale in Ontario. Further to the OICR-FACIT translational mandate, this strategy ensures investments in research have the best opportunity to impact care for patients with cancer.